Clinical Trial: A Single-Arm, Open-Label Phase I Clinical Study on the Safety, Tolerability, and Preliminary Efficacy of LDH/EDTA Combined with Pirarubicin in the Treatment of Patients with Non-Muscle-Invasive Bladder Cancer (China)

China, Sept. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Arm, Open-Label Phase I Clinical Study on the Safety, Tolerability, and Preliminary Efficacy of LDH/EDTA Combined with Pirarubicin in the Treatment of Patients with Non-Muscle-Invasive Bladder Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132315

Registration Time: 2026/09/11

Type: Interventional study

Primary Sponsor: Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=302918

Published by HT Digital Content Services with permission from Health Daily Digest....